MET-Targeted Therapies and Clinical Outcomes: A Systematic Literature Review-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

MET-Targeted Therapies and Clinical Outcomes: A Systematic Literature Review

Published:2022-03 Issue:2 Volume:26 Page:203-227
ISSN:1177-1062
Container-title:Molecular Diagnosis & Therapy
language:en
Short-container-title:Mol Diagn Ther

Author:

Dong Yiting,Xu Jiachen,Sun Boyang,Wang Jie,Wang Zhijie

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology,Genetics,Molecular Medicine,General Medicine

Link

https://link.springer.com/content/pdf/10.1007/s40291-021-00568-w.pdf

Reference96 articles.

1. Yan L, Rosen N, Arteaga C. Targeted cancer therapies. Chin J Cancer. 2011;30:1–4.

2. Ke X. Molecular targeted therapy of cancer: the progress and future prospect. Front Lab Med. 2017;1:69–75.

3. De Bono JS, Yap TA. c-MET: an exciting new target for anticancer therapy. Ther Adv Med Oncol. 2011;3:S3-5.

4. Koch JP, Aebersold DM, Zimmer Y, Medová M. MET targeting: time for a rematch. Oncogene. 2020;39:2845–62.

5. Comoglio PM, Trusolino L, Boccaccio C. Known and novel roles of the MET oncogene in cancer: a coherent approach to targeted therapy. Nat Rev Cancer. 2018;18:341–58.

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Understanding mechanisms of resistance to FLT3 inhibitors in adult FLT3-mutated acute myeloid leukemia to guide treatment strategy;Critical Reviews in Oncology/Hematology;2024-09

2. AI Predictive Modeling of Survival Outcomes for Renal Cancer Patients Undergoing Targeted Therapy;2024-07-03

3. A Review of the Molecular Determinants of Therapeutic Response in Non-Small Cell Lung Cancer Brain Metastases;International Journal of Molecular Sciences;2024-06-26

4. Mesenchymal-epithelial transition factor amplification correlates with adverse pathological features and poor clinical outcome in colorectal cancer;World Journal of Gastrointestinal Surgery;2024-05-27

5. Advances in MET tyrosine kinase inhibitors in gastric cancer;Cancer Biology & Medicine;2024-05-10

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3